Generate a tailored SOP for Dr. Andrew Fleetwood. Improve your application with a focused, well-structured draft.
Andrew Fleetwood obtained a BSc (Hons) and a PhD from the Department of Medicine at The University of Melbourne. His doctoral work was completed in the laboratories of Professor John Hamilton at Melbourne University and Professor Toby Lawrence at the Kennedy Institute of Rheumatology in London. Fleetwood's research has primarily focused on characterizing pathways that control macrophage activation, resulting in publications detailing molecular pathways that regulate macrophage polarization, with over 340 citations in the Journal of Immunology. Following his PhD, he spent four years in the pharmaceutical industry as a postdoctoral researcher in the Inflammation and Autoimmunity Division at Novo Nordisk in Copenhagen, Denmark, where he developed novel therapeutics aimed at targeting aberrant myeloid cell function in chronic inflammatory conditions. In 2012, he returned to The University of Melbourne to further investigate the roles of monocytes and macrophages in disease. Recently, his work has explored how metabolic pathways influence immune cell function and epigenetic memory. He has published 30 papers across journals such as the Journal of Immunology, Journal of Biological Chemistry, and Journal of Clinical Investigation. In July 2020, he joined Associate Professor Andrew Murphy’s laboratory at the Baker Institute and holds honorary appointments at the Baker Department of Cardiometabolic Health and the Department of Medicine at The University of Melbourne.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.